Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Rumors Perrigo Co. (PRGO) Acquiring Akorn (AKRX) 'Likely Not True' - Cantor Fitzgerald
-
Two Pieces of Good News for Amarin (AMRN) - Cantor Fitzgerald
-
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
-
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
-
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
-
Dermira (DERM) Trades Above Deal Price on Speculation of Higher Bid
-
Aptinyx (APTX) Prices 10.17M Share Common Stock Offering at $3/shh
-
Aptinyx Announces Pricing of Public Offering of Common Stock
-
Aptinyx Announces Pricing of Public Offering of Common Stock
-
Intuitive Surgical (ISRG) PT Raised to 'Street High' $690 at Cantor Fitzgerald on Strong Q4
-
Cidara Therapeutics (CDTX) Announces Proposed $30M Rights Offering
-
Cidara Therapeutics Announces Proposed Rights Offering
-
Apellis Pharmaceuticals (APLS) Prices 9.5M Share Offering at $37/Sh
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Phreesia Inc. (PHR) at Overweight
-
Cantor Fitzgerald Starts BiomX (PHGE) at Overweight
-
Cantor Fitzgerald Defends Amarin (AMRN), Says Headlines 'Noise'
-
Amarin Corporation (AMRN) Updated Guidance In Line, Cantor Fitzgerald Reiterates Outperform
-
Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh
-
Intra-Cellular Therapies Prices Public Offering of Common Stock
-
Hecla Mining (HL) PT Raised to $4 at Cantor Fitzgerald, After Reporting 22% Higher Silver and 4% Higher Gold Production
-
Apellis Pharmaceuticals (APLS) Data Exceeded Expectations, Expect Shares to Fly - Cantor Fitzgerald
-
Amarin Corporation (AMRN) Expenses May Drive Expenses Higher but Vascepa Peak Sales Remains the Key for Investors - Cantor Fitzgerald
-
Incyte (INCY) PT Lowered to $65 at Cantor Fitzgerald
-
Health Canada Approval Underscores Global Market Opportunity for Amarin's (AMRN) Vascepa - Cantor Fitzgerald
-
Wall Street starts 2020 with new records on China stimulus, trade hopes
-
Aurora Cannabis (ACB:CN) (ACB) PT Lowered to Cdn$5 at Cantor Fitzgerald
-
Energy Fuels Renews Its ATM Program
-
Evolent Health (EVH) Closed Passport Deal and Improved Balance Sheet - Cantor Fitzgerald
-
Axsome Therapeutics (AXSM) PT Raised to $125 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral
-
Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Cantor Fitzgerald Starts Stemline Therapeutics (STML) at Overweight
-
Cantor Fitzgerald Starts Taiwan Liposome Co. Ltd. (TLC) at Overweight
-
Roche dives deeper into gene therapy with $1.15 billion Sarepta licensing deal
-
Health Insurance Innovations (HIIQ) Update Suggests 'Solid Financial Stability' - Cantor Fitzgerald
-
Amarin's (AMRN) Vascepa Rxs Continue To Show Positive Trends - Cantor Fitzgerald
-
Arvinas Inc's (ARVN) Opportunity in PROTAC is at the Beginning, PT Raised to $75 at Cantor Fitzgerald
-
BGC Partners (BGCP) Appoints CFO and Announces Additional Leadership Changes
-
BGC Partners Appoints CFO and Announces Additional Leadership Changes in Global Brokerage Business
-
Act II Global Acquisition Corp. to Combine with Flavors Holdings Inc. Subsidiaries Merisant Company and MAFCO Worldwide LLC to Form Whole Earth Brands
-
Cantor Fitzgerald and Silverstein Properties Close Opportunity Zone Land Acquisition in Las Vegas, NV
-
Manage Care Stocks Gain on 'Positive' ACA Court Ruling
-
Selecta Biosciences (SELB) Announces $70 Million Private Placement of Common Stock, Warrants
-
Selecta Biosciences Announces $70 Million Private Placement
-
Axsome Therapeutics (AXSM) Prices 2M Share Offering at $87
-
Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock

